ZA962271B - Peroral controlled release composition - Google Patents

Peroral controlled release composition

Info

Publication number: ZA962271B
Authority: ZA; South Africa
Prior art keywords: composition; drug; pct; controlling agent; peroral
Prior art date: 1995-03-21

Application number

ZA962271A

Other languages

English (en)

Inventor

Martti Marvola

Esko Marttila

Reija Yrjola

Esa Lahdenpaa

Original Assignee

Orion Yhtymae Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-21

Filing date

1996-03-20

Publication date

1996-09-30

1996-03-20 Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy

1996-09-30 Publication of ZA962271B publication Critical patent/ZA962271B/xx

Links

238000013270 controlled release Methods 0.000 title abstract 2
239000003814 drug Substances 0.000 abstract 6
229940079593 drug Drugs 0.000 abstract 6
239000003795 chemical substances by application Substances 0.000 abstract 3
239000002702 enteric coating Substances 0.000 abstract 2
238000009505 enteric coating Methods 0.000 abstract 2
239000008187 granular material Substances 0.000 abstract 2
229920000642 polymer Polymers 0.000 abstract 2
WXGVASWIUBFCHW-UHFFFAOYSA-N 3-(2-acetyl-3-oxobut-1-enyl)benzonitrile Chemical compound CC(=O)C(C(C)=O)=CC1=CC=CC(C#N)=C1 WXGVASWIUBFCHW-UHFFFAOYSA-N 0.000 abstract 1
210000001072 colon Anatomy 0.000 abstract 1
210000003750 lower gastrointestinal tract Anatomy 0.000 abstract 1
239000011159 matrix material Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA962271A 1995-03-21 1996-03-20 Peroral controlled release composition ZA962271B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FI951316A FI98343C (fi)	1995-03-21	1995-03-21	Peroraalinen formulaatio

Publications (1)

Publication Number	Publication Date
ZA962271B true ZA962271B (en)	1996-09-30

Family

ID=8543092

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA962271A ZA962271B (en)	1995-03-21	1996-03-20	Peroral controlled release composition

Country Status (16)

Country	Link
US (1)	US5962024A (de)
EP (1)	EP0817615B1 (de)
JP (1)	JPH11502217A (de)
AT (1)	ATE221771T1 (de)
AU (1)	AU694849B2 (de)
CA (1)	CA2213747A1 (de)
DE (1)	DE69622850T2 (de)
DK (1)	DK0817615T3 (de)
ES (1)	ES2181874T3 (de)
FI (1)	FI98343C (de)
IL (1)	IL117582A (de)
NO (1)	NO312705B1 (de)
NZ (1)	NZ303683A (de)
PT (1)	PT817615E (de)
WO (1)	WO1996029058A1 (de)
ZA (1)	ZA962271B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998024412A2 (en) *	1996-12-05	1998-06-11	The Board Of Trustees Of The University Of Illinois	Compounds useful against diseases of the colon and methods for orally administering same
DE19732903A1 (de)	1997-07-30	1999-02-04	Falk Pharma Gmbh	Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6110500A (en) *	1998-03-25	2000-08-29	Temple University	Coated tablet with long term parabolic and zero-order release kinetics
US6932861B2 (en)	2000-11-28	2005-08-23	Fmc Corporation	Edible PGA coating composition
US20040106590A1 (en) *	2002-08-29	2004-06-03	Barry Eisenstein	Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
US20050025829A1 (en) *	2003-07-29	2005-02-03	Kim Cherng-Ju	Controlled drug release tablets
US8709476B2 (en)	2003-11-04	2014-04-29	Supernus Pharmaceuticals, Inc.	Compositions of quaternary ammonium compounds containing bioavailability enhancers
DK2210605T3 (en) *	2003-11-04	2017-05-22	Tcd Royalty Sub Llc	Daily single dose doses of trospium.
JP2008525313A (ja)	2004-12-27	2008-07-17	エーザイ・アール・アンド・ディー・マネジメント株式会社	抗痴呆薬の安定化方法
US20060159753A1 (en) *	2004-12-27	2006-07-20	Eisai Co. Ltd.	Matrix type sustained-release preparation containing basic drug or salt thereof
EP1912629A4 (de) *	2005-07-08	2012-09-12	Univ Arkansas	Asymmetrisch beschichtete tablette
US8357394B2 (en) *	2005-12-08	2013-01-22	Shionogi Inc.	Compositions and methods for improved efficacy of penicillin-type antibiotics
US20080139526A1 (en) *	2006-12-06	2008-06-12	Donald Treacy	Modified release dosage forms of amoxicillin
US8299052B2 (en) *	2006-05-05	2012-10-30	Shionogi Inc.	Pharmaceutical compositions and methods for improved bacterial eradication
US7713549B2 (en) *	2006-06-30	2010-05-11	Board Of Trustees Of The University Of Arkansas	Extended release perforated tablet
US20090036414A1 (en) *	2007-08-02	2009-02-05	Mutual Pharmaceutical Company, Inc.	Mesalamine Formulations
CN102238868A (zh)	2008-10-03	2011-11-09	福尔克博士药物有限责任公司	使用颗粒状5-氨基水杨酸治疗肠病的组合物和方法
CN102223880B (zh) *	2008-11-25	2017-04-26	田边三菱制药株式会社	口腔速崩片及其制备方法
JP6203816B2 (ja)	2012-03-29	2017-09-27	セラバイオーム，エルエルシー	回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤
AU2014239883B2 (en)	2013-03-14	2019-01-17	Therabiome, Llc	Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
MD3684344T2 (ro) *	2017-10-25	2025-09-30	Chiesi Farm Spa	Comprimate de deferipronă cu eliberare întârziată și metode de utilizare a acestora
IT201800011120A1 (it) *	2018-12-14	2020-06-14	Dpl Pharma S P A	Composizioni farmaceutiche orali solide per la somministrazione di mesalazina o suoi derivati

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9002337D0 (en) *	1990-02-02	1990-04-04	Orion Yhtymae Oy	Compounds useful in treating inflammatory bowel disease
PT93637A (pt) *	1989-04-20	1990-11-20	Procter & Gamble	Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
JPH0334928A (ja) *	1989-06-29	1991-02-14	Teikoku Seiyaku Kk	潰瘍性大腸炎およびクローン病治療用経口投与製剤
US5209933A (en) *	1990-01-10	1993-05-11	Syntex (U.S.A.) Inc.	Long acting calcium channel blocker composition
WO1992016214A1 (en) *	1991-03-15	1992-10-01	Norwich Eaton Pharmaceuticals Inc.	The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
SE501389C2 (sv) *	1992-04-24	1995-01-30	Leiras Oy	Farmaceutiskt preparat och förfarande för dess framställning

1995
- 1995-03-21 FI FI951316A patent/FI98343C/fi not_active IP Right Cessation
1996
- 1996-03-20 WO PCT/FI1996/000164 patent/WO1996029058A1/en not_active Ceased
- 1996-03-20 EP EP96906784A patent/EP0817615B1/de not_active Expired - Lifetime
- 1996-03-20 IL IL11758296A patent/IL117582A/xx not_active IP Right Cessation
- 1996-03-20 JP JP8528112A patent/JPH11502217A/ja not_active Ceased
- 1996-03-20 AU AU50061/96A patent/AU694849B2/en not_active Ceased
- 1996-03-20 US US08/913,554 patent/US5962024A/en not_active Expired - Fee Related
- 1996-03-20 CA CA002213747A patent/CA2213747A1/en not_active Abandoned
- 1996-03-20 ZA ZA962271A patent/ZA962271B/xx unknown
- 1996-03-20 ES ES96906784T patent/ES2181874T3/es not_active Expired - Lifetime
- 1996-03-20 PT PT96906784T patent/PT817615E/pt unknown
- 1996-03-20 DE DE69622850T patent/DE69622850T2/de not_active Expired - Fee Related
- 1996-03-20 NZ NZ303683A patent/NZ303683A/en unknown
- 1996-03-20 DK DK96906784T patent/DK0817615T3/da active
- 1996-03-20 AT AT96906784T patent/ATE221771T1/de not_active IP Right Cessation
1997
- 1997-08-27 NO NO19973950A patent/NO312705B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU5006196A (en)	1996-10-08
FI98343C (fi)	1997-06-10
US5962024A (en)	1999-10-05
ATE221771T1 (de)	2002-08-15
NO312705B1 (no)	2002-06-24
ES2181874T3 (es)	2003-03-01
NO973950D0 (no)	1997-08-27
IL117582A0 (en)	1996-07-23
NZ303683A (en)	1998-07-28
CA2213747A1 (en)	1996-09-26
FI951316A0 (fi)	1995-03-21
DK0817615T3 (da)	2002-11-25
PT817615E (pt)	2002-12-31
WO1996029058A1 (en)	1996-09-26
AU694849B2 (en)	1998-07-30
EP0817615B1 (de)	2002-08-07
DE69622850D1 (de)	2002-09-12
DE69622850T2 (de)	2003-04-24
FI98343B (fi)	1997-02-28
FI951316L (fi)	1996-09-22
IL117582A (en)	2000-02-29
NO973950L (no)	1997-08-27
EP0817615A2 (de)	1998-01-14
JPH11502217A (ja)	1999-02-23

Publication	Publication Date	Title
IL117582A (en)	2000-02-29	Peroral controlled release composition
DE69630375D1 (de)	2003-11-20	Pharmazeutische dosierungsform zur freisetzung im colon
DE69619668D1 (de)	2002-04-11	Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon
CA2268868A1 (en)	1998-04-23	Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
CA2268175A1 (en)	1998-04-23	Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
NZ511448A (en)	2003-06-30	A dosage form of diltiazem that exhibits a release rate profile corresponding to a "two peak" plasma level profile in vivo
MX9605646A (es)	1997-06-28	Preparacion de nifedipino de liberacion prolongada.
NZ260365A (en)	1994-08-26	Controlled release drug delivery device; solid core, delay coating, semi-permeable membrane, outer enteric coating
ID17428A (id)	1997-12-24	Sediaan farmasi da;lam bentuk kapsult bersalut yang dapat dilepas pada bagian bawah saluran pencernaan
EP0814780A4 (de)	2000-03-15	Diltiazem-formulierung mit gesteuerter freigabe
EP1736144A3 (de)	2010-12-29	Im Munde zerfallende Tablette
WO2002024174A3 (en)	2002-09-26	Sustained release composition containing clarithromycin
ATE345781T1 (de)	2006-12-15	Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe
BR9806174A (pt)	1999-10-19	Péletes tendo um núcleo revestido com um antifúngico e um polìmero
DE60036874D1 (de)	2007-12-06	Pellet formulierung mit gesteuerter freisetzung
ATE291901T1 (de)	2005-04-15	Neue omeprazole und (s)-omeprazole zusammensetzung
PL307262A1 (en)	1995-05-15	Controllable release morphine preparation
HU9301499D0 (en)	1993-09-28	Preparatives of controlled releasing of active agents
DE59709645D1 (de)	2003-04-30	Lutschtablette zur modifizierten freisetzung von wirkstoffen im gastrointestinaltrakt
WO1996029058B1 (en)	1996-10-24	Peroral composition for controlled release in the lower gastrointestinal tract
CA2271569A1 (en)	1998-05-28	Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
CA2271560A1 (en)	1998-05-28	Pharmaceutical dosage form for colonic delivery
BR9612800A (pt)	2000-03-28	Forma de dosagem farmacêutica para distribuição colÈnica.
TH22631A (th)	1996-12-27	ลูกกลมแบบใหม่สำหรับควบคุมการปล่อยสารและการเตรียมยาที่ประกอบด้วยลูกกลมชนิดเดียวกัน
BR9612801A (pt)	2000-03-28	Forma de dosagem farmacêutica com múltiplos revestimentos de polìmeros entéricos para o fornecimento colÈnico.